Cargando…
Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d
Invariant Natural Killer T-cells (iNKT-cells) are an attractive target for immune response modulation, as upon CD1d-mediated stimulation with KRN7000, a synthetic α-galactosylceramide, they produce a vast amount of cytokines. Here we present a synthesis that allows swift modification of the phytosph...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487351/ https://www.ncbi.nlm.nih.gov/pubmed/28655912 http://dx.doi.org/10.1038/s41598-017-04461-7 |
_version_ | 1783246443214012416 |
---|---|
author | Guillaume, Joren Wang, Jing Janssens, Jonas Remesh, Soumya G. Risseeuw, Martijn D. P. Decruy, Tine Froeyen, Mathy Elewaut, Dirk Zajonc, Dirk M. Calenbergh, Serge Van |
author_facet | Guillaume, Joren Wang, Jing Janssens, Jonas Remesh, Soumya G. Risseeuw, Martijn D. P. Decruy, Tine Froeyen, Mathy Elewaut, Dirk Zajonc, Dirk M. Calenbergh, Serge Van |
author_sort | Guillaume, Joren |
collection | PubMed |
description | Invariant Natural Killer T-cells (iNKT-cells) are an attractive target for immune response modulation, as upon CD1d-mediated stimulation with KRN7000, a synthetic α-galactosylceramide, they produce a vast amount of cytokines. Here we present a synthesis that allows swift modification of the phytosphingosine side chain by amidation of an advanced methyl ester precursor. The resulting KRN7000 derivatives, termed α-galactosylsphingamides, were evaluated for their capacity to stimulate iNKT-cells. While introduction of the amide-motif in the phytosphingosine chain is tolerated for CD1d binding and TCR recognition, the studied α-galactosylsphingamides showed compromised antigenic properties. |
format | Online Article Text |
id | pubmed-5487351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-54873512017-06-30 Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d Guillaume, Joren Wang, Jing Janssens, Jonas Remesh, Soumya G. Risseeuw, Martijn D. P. Decruy, Tine Froeyen, Mathy Elewaut, Dirk Zajonc, Dirk M. Calenbergh, Serge Van Sci Rep Article Invariant Natural Killer T-cells (iNKT-cells) are an attractive target for immune response modulation, as upon CD1d-mediated stimulation with KRN7000, a synthetic α-galactosylceramide, they produce a vast amount of cytokines. Here we present a synthesis that allows swift modification of the phytosphingosine side chain by amidation of an advanced methyl ester precursor. The resulting KRN7000 derivatives, termed α-galactosylsphingamides, were evaluated for their capacity to stimulate iNKT-cells. While introduction of the amide-motif in the phytosphingosine chain is tolerated for CD1d binding and TCR recognition, the studied α-galactosylsphingamides showed compromised antigenic properties. Nature Publishing Group UK 2017-06-27 /pmc/articles/PMC5487351/ /pubmed/28655912 http://dx.doi.org/10.1038/s41598-017-04461-7 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Guillaume, Joren Wang, Jing Janssens, Jonas Remesh, Soumya G. Risseeuw, Martijn D. P. Decruy, Tine Froeyen, Mathy Elewaut, Dirk Zajonc, Dirk M. Calenbergh, Serge Van Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d |
title | Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d |
title_full | Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d |
title_fullStr | Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d |
title_full_unstemmed | Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d |
title_short | Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d |
title_sort | galactosylsphingamides: new α-galcer analogues to probe the f’-pocket of cd1d |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487351/ https://www.ncbi.nlm.nih.gov/pubmed/28655912 http://dx.doi.org/10.1038/s41598-017-04461-7 |
work_keys_str_mv | AT guillaumejoren galactosylsphingamidesnewagalceranaloguestoprobethefpocketofcd1d AT wangjing galactosylsphingamidesnewagalceranaloguestoprobethefpocketofcd1d AT janssensjonas galactosylsphingamidesnewagalceranaloguestoprobethefpocketofcd1d AT remeshsoumyag galactosylsphingamidesnewagalceranaloguestoprobethefpocketofcd1d AT risseeuwmartijndp galactosylsphingamidesnewagalceranaloguestoprobethefpocketofcd1d AT decruytine galactosylsphingamidesnewagalceranaloguestoprobethefpocketofcd1d AT froeyenmathy galactosylsphingamidesnewagalceranaloguestoprobethefpocketofcd1d AT elewautdirk galactosylsphingamidesnewagalceranaloguestoprobethefpocketofcd1d AT zajoncdirkm galactosylsphingamidesnewagalceranaloguestoprobethefpocketofcd1d AT calenberghsergevan galactosylsphingamidesnewagalceranaloguestoprobethefpocketofcd1d |